Mental Health Clinics in Jeannette, PA Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Seyler - Berkebile Marriage & Family Therapy Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 1215 N Greengate Rd, Ste D, Jeannette, PA 15644 Phone: 724-832-1700 Fax: 724-853-6704 |
Caring Conversations Therputic Services Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 714 Lewis Ave, Jeannette, PA 15644 Phone: 724-201-9815 |
Mercy Jeannette Hospital Hospital Units - Psychiatric Unit Medicare: Not Enrolled in Medicare Practice Location: 600 Jefferson Ave, Jeannette, PA 15644 Phone: 724-527-9120 Fax: 724-527-9430 |
News Archive
Study shows people with SE-AN can be treated with outpatient treatment programme
Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.
Cynosure obtains European MDD certification for SculpSure
Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received European Medical Device Directive (MDD) certification from its European Notified Body for SculpSure, the world's first hyperthermic aesthetic laser for non-invasive fat reduction. The certification, from Intertek Semko AB, allows Cynosure to place the "CE" Mark on SculpSure for distribution in the European Union and its member states.
New study shows health impacts of eating plant-based diet
Eating a vegetarian or primarily plant-based diet is associated with a variety of health benefits. But simply being vegetarian is not enough to reap those benefits-;the quality of the food matters, too.
Cytheris commences enrollment in CYT107 recombinant human Interleukin-7 clinical trial for HIV
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).
› Verified 7 days ago